Amgen (AMGN) Non Operating Income (2009 - 2026)

Amgen (AMGN) has reported Non Operating Income for 18 consecutive years, with $75.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non Operating Income fell 95.06% year-over-year to $75.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (down 46.53% YoY), while the FY2025 annual figure was $2.7 billion, up 423.91% from the prior year.
• Non Operating Income came in at $75.0 million for Q1 2026 at Amgen, up from -$553.0 million in the prior quarter.
• The five-year high for Non Operating Income was $2.1 billion in Q3 2025, with the low at -$782.0 million in Q4 2024.
• Average Non Operating Income over 5 years is $308.9 million, with a median of -$67.0 million recorded in 2022.
• Across the five-year window, Non Operating Income slumped 4176.92% in 2022 and surged 745.96% in 2025, its largest moves.
• Year by year, Non Operating Income stood at -$67.0 million in 2022, then surged by 700.0% to $402.0 million in 2023, then slumped by 294.53% to -$782.0 million in 2024, then climbed by 29.28% to -$553.0 million in 2025, then jumped by 113.56% to $75.0 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $75.0 million, -$553.0 million, and $2.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.